Oncotelic Therapeutics, Inc. (OTLC)
0.079
0.00 (0.00%)
USD |
OTCM |
Jan 02, 10:59
Oncotelic Therapeutics EPS Diluted (Quarterly): -0.0025 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| Merck & Co., Inc. | 2.316 |
| Pfizer Inc. | 0.6197 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.114M |
| Total Expenses (Quarterly) | 1.047M |
| Enterprise Value | 47.84M |
| Earnings Yield | -5.19% |
| Normalized Earnings Yield | -4.177 |